| Literature DB >> 27895788 |
Cunzhen Shi1, Xudong Zhang1, Xin Li1, Lei Zhang1, Ling Li1, Zhenchang Sun1, Xiaorui Fu1, Jingjing Wu1, Yu Chang1, Wencai Li2, Qingjiang Chen1, Mingzhi Zhang3.
Abstract
Previous studies have demonstrated that microRNA-21 (miR-21) is an oncogene and is significantly upregulated in tumor tissue. However, its association with T-cell acute lymphoblastic lymphoma/leukemia (T-ALL) remains poorly understood. The aim of the present study was to investigate the effects of miR-21 on T-ALL cells by constructing Jurkat cells infected with recombinant adenovirus adv-miR-21 or adv-anti-miR-21. In addition, the target gene of miR-21 was identified by reverse transcription-quantitative polymerase chain reaction and western blotting. The results demonstrated that miR-21 expression in Jurkat cells was markedly upregulated. Furthermore, upregulating miR-21 expression in Jurkat cells promoted cell proliferation and invasion and decreased the apoptosis rate. By contrast, knockdown of miR-21 in Jurkat cells suppressed proliferation and invasion and increased the apoptosis rate. Furthermore, the results indicated that signal transducer and activator of transcription (STAT) 3 was targeted by miR-21, and that miR-21 inhibited STAT3 expression at the protein level rather than at the messenger RNA level. In conclusion, targeting the inhibition of miR-21 may be a novel therapeutic strategy for patients with T-ALL.Entities:
Keywords: T-cell acute lymphoblastic lymphoma/leukemia; feedback; microRNA-21; signal transducer and activator of transcription 3; target gene
Year: 2016 PMID: 27895788 PMCID: PMC5104253 DOI: 10.3892/ol.2016.5163
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967